Form 4: Leidos Holdings Director Noel B. Geer Reports Stock Option Grant and Stock Transactions
SEC Form 4
Director Noel B. Geer of Leidos Holdings, Inc. reports the acquisition of stock options and shares, as well as a disposition of shares held by a family trust.
Summary
- On May 3, 2024, Noel B. Geer, a director of Leidos Holdings, Inc., reported transactions involving the company's stock.
- Geer acquired 912 shares of common stock at $0.
- Geer was granted stock options for 1,179 shares with an exercise price of $142.66, exercisable starting May 3, 2025, and expiring on May 2, 2031.
- Geer also reported the disposition of 30,836.8435 shares of common stock held indirectly by a family trust, reducing the holdings to 29,894 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of shares and options is mildly positive, while the disposition by the family trust is mildly negative. Overall, it's a balanced report.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Negatives
- The disposition of 30,836.8435 shares by a family trust could be interpreted negatively, although the remaining holdings are still substantial at 29,894 shares.
Risks
- The stock options have an exercise price of $142.66, so their value is dependent on the stock price exceeding that level before the expiration date.
Future Outlook
The document does not contain explicit forward-looking statements, but the granting of stock options suggests an expectation of future stock price appreciation.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders, which can be informative for investors.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- The details provided are consistent with regulatory requirements for disclosing changes in beneficial ownership.
Stakeholder Impact
- Shareholders may be interested in the transactions of company directors as an indicator of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Date of stock and option transactions. |
| 05/03/2025 | Earliest date the stock options become fully exercisable. |
| 05/02/2031 | Expiration date of the stock options. |
| 05/07/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.